Skip to main content

Advertisement

SpringerLink
Log in

Fertility sparing surgery for stage IA type I and G2 endometrial cancer in reproductive-aged patients: evidence-based approach and future perspectives

  • Review Article
  • Published:
Updates in Surgery Aims and scope Submit manuscript

Abstract

Fertility-sparing surgery (FSS) in reproductive-age patients affected by endometrial cancer (EC) gained growing attention in the last decade, although the first reports were already published in 1990–2000s. Nevertheless, only few patients undergoing FSS for stage I, type I EC had been reported in each case series, without a robust multicenter study. In the available literature there are even fewer reported cases of conservative treatment of Stage IA and G2 EC. Considering these important gaps in our current knowledge, the purpose of this review was to summarize the available evidence about conservative treatments for stage IA type I and G2 EC, to improve the pretreatment counseling for reproductive-age patients. According to our overview, women who have low-risk disease (G1 or G2, endometrioid histotype confined to the endometrium) are candidates for progestin therapy. In addition, FSS could be considered a valid option for reproductive-aged patients with stage IA type I and G2 EC. Nevertheless, we solicit new trials to clarify the medium- and long-term outcomes in this kind of patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Vitale SG, Valenti G, La Rosa VL, Laganà AS (2016) Comment on “Laparoscopic myomectomy of a symptomatic uterine leiomyoma in a 15-year-old adolescent”. J Pediatr Adolesc Gynecol. doi:10.1016/j.jpag.2016.11.013

    PubMed  Google Scholar 

  2. Vitale SG, Gasbarro N, Lagana AS et al (2016) Safe introduction of ancillary trocars in gynecological surgery: the “yellow island” anatomical landmark. Ann Ital Chir 87:608–611

    PubMed  Google Scholar 

  3. Giacobbe V, Rossetti D, Vitale SG et al (2016) Otorrhagia and nosebleed as first signs of intravascular absorption syndrome during hysteroscopy: from bench to bedside. Kathmandu Univ Med J 14:87–89

    CAS  Google Scholar 

  4. Laganà AS, Vitale SG, Palmara V et al (2016) Transvaginal specimen removal in minimally invasive surgery: feasibility and possible complications during the incision of the posterior vaginal wall. World J Urol. doi:10.1007/s00345-016-1955-7

    Google Scholar 

  5. Butticè S, Sener TE, Lucan VC et al (2016) Hybrid transvaginal NOTES nephrectomy: postoperative sexual outcomes. A three-center matched study. Urology 99:131–135. doi:10.1016/j.urology.2016.09.023

    Article  PubMed  Google Scholar 

  6. Laganà AS, Vitale SG, Trovato MA et al (2016) Full-thickness excision versus shaving by laparoscopy for intestinal deep infiltrating endometriosis: rationale and potential treatment options. Biomed Res Int 2016:3617179. doi:10.1155/2016/3617179

    Article  PubMed  PubMed Central  Google Scholar 

  7. Lagana AS, Vitale SG, De Dominici R et al (2016) Fertility outcome after laparoscopic salpingostomy or salpingectomy for tubal ectopic pregnancy A 12-years retrospective cohort study. Ann Ital Chir 87:461–465

    PubMed  Google Scholar 

  8. Laganà AS, Sapia F, Butticè S et al (2016) Comment on “efficacy and safety of skeletonized mesh implants for advanced pelvic organ prolapse: 12 month follow up”. World J Urol 34:1499–1500. doi:10.1007/s00345-016-1858-7

    Article  PubMed  Google Scholar 

  9. Laganà AS, Sofo V, Salmeri FM et al (2016) Oxidative stress during ovarian torsion in pediatric and adolescent patients: changing the perspective of the disease. Int J Fertil Steril 9:416–423

    PubMed  Google Scholar 

  10. Vitale SG, Laganà AS, Rapisarda AM (2016) Letter to the editor: comment on “Simultaneous treatment of anterior vaginal wall prolapse and stress urinary incontinence by using transobturator four arms polypropylene mesh”. Investig Clin Urol 57:150–151. doi:10.4111/icu.2016.57.2.150

    Article  PubMed  PubMed Central  Google Scholar 

  11. Vitale SG, Laganà AS, Gulino FA et al (2016) Prosthetic surgery versus native tissue repair of cystocele: literature review. Updates Surg 68:325–329. doi:10.1007/s13304-015-0343-y

    Article  PubMed  Google Scholar 

  12. Laganà AS, Santoro G, Triolo O et al (2015) Hashimoto thyroiditis onset after laparoscopic removal of struma ovarii: an overview to unravel a rare and intriguing finding. Clin Exp Obstet Gynecol 42:673–678

    PubMed  Google Scholar 

  13. Ciancimino L, Laganà AS, Imbesi G et al (2015) Evaluation of maternal-fetal outcomes after emergency vaginal cerclage performed with Shirodkar–McDonald combined modified technique. J Clin Med Res 7:319–323. doi:10.14740/jocmr2108w

    Article  PubMed  PubMed Central  Google Scholar 

  14. Laganà AS, Colonese F, Colonese E et al (2015) Cytogenetic analysis of epithelial ovarian cancer’s stem cells: an overview on new diagnostic and therapeutic perspectives. Eur J Gynaecol Oncol 36:495–505

    PubMed  Google Scholar 

  15. Bellia A, Vitale SG, Laganà AS et al (2016) Feasibility and surgical outcomes of conventional and robot-assisted laparoscopy for early-stage ovarian cancer: a retrospective, multicenter analysis. Arch Gynecol Obstet 294:615–622. doi:10.1007/s00404-016-4087-9

    Article  PubMed  Google Scholar 

  16. Vitale SG, Marilli I, Lodato M et al (2013) The role of cytoreductive surgery in advanced-stage ovarian cancer: a systematic review. Updates Surg 65:265–270. doi:10.1007/s13304-013-0213-4

    Article  PubMed  Google Scholar 

  17. Rossetti D, Vitale SG, Gulino FA et al (2016) Laparoendoscopic single-site surgery for the assessment of peritoneal carcinomatosis resectability in patients with advanced ovarian cancer. Eur J Gynaecol Oncol 37:671–673. doi:10.12892/ejgo3234.2016

    Google Scholar 

  18. Vitale SG, Valenti G, Gulino FA et al (2016) Surgical treatment of high stage endometrial cancer: current perspectives. Updates Surg 68:149–154. doi:10.1007/s13304-015-0340-1

    Article  PubMed  Google Scholar 

  19. Rossetti D, Bogani G, Carnelli M et al (2014) Efficacy of IVF following conservative management of endometrial cancer. Gynecol Endocrinol 30:280–281. doi:10.3109/09513590.2014.892065

    Article  PubMed  Google Scholar 

  20. Rossetti D, Vitale SG, Gulino FA et al (2016) Concomitant chemoradiation treatment in selected Stage I endometrioid endometrial cancers. Eur J Gynaecol Oncol 37:657–661. doi:10.12892/ejgo3125.2016

    Google Scholar 

  21. Bentivegna E, Gouy S, Maulard A et al (2016) Oncological outcomes after fertility-sparing surgery for cervical cancer: a systematic review. Lancet Oncol 17:e240–e253. doi:10.1016/S1470-2045(16)30032-8

    Article  PubMed  Google Scholar 

  22. de Hullu JA, van der Avoort IA, Oonk MH, van der Zee AG (2006) Management of vulvar cancers. Eur J Surg Oncol 32:825–831. doi:10.1016/j.ejso.2006.03.035

    Article  PubMed  Google Scholar 

  23. Vitale SG, Valenti G, Biondi A et al (2015) Recent trends in surgical and reconstructive management of vulvar cancer: review of literature. Updates Surg 67:367–371. doi:10.1007/s13304-015-0303-6

    Article  PubMed  Google Scholar 

  24. Laganà AS, La Rosa V, Petrosino B, Vitale SG (2017) Comment on “Risk of developing major depression and anxiety disorders among women with endometriosis: a longitudinal follow-up study”. J Affect Disord 208:672–673. doi:10.1016/j.jad.2016.07.016

    Article  PubMed  Google Scholar 

  25. Vitale SG, La Rosa VL, Rapisarda AM, Laganà AS (2017) Comment on: “Impact of endometriosis on quality of life and mental health: pelvic pain makes the difference”. J Psychosom Obstet Gynecol 38:81–82. doi:10.1080/0167482X.2016.1244183

    Article  Google Scholar 

  26. Vitale SG, La Rosa VL, Rapisarda AM, Laganà AS (2016) Impact of endometriosis on quality of life and psychological well-being. J Psychosom Obstet Gynecol. doi:10.1080/0167482X.2016.1244185

    Google Scholar 

  27. Laganà AS, La Rosa VL, Rapisarda AM, Vitale S (2017) Comment on: “Needs and priorities of women with endometrial and cervical cancer”. J Psychosom Obstet Gynecol 38:85–86. doi:10.1080/0167482X.2016.1244186

    Article  Google Scholar 

  28. Vitale SG, La Rosa VL, Rapisarda AM, Laganà AS (2017) Comment on: “Anxiety and depression in patients with advanced ovarian cancer: a prospective study”. J Psychosom Obstet Gynecol 38:83–84. doi:10.1080/0167482X.2016.1244182

    Article  Google Scholar 

  29. Vitale SG, La Rosa VL, Rapisarda AM, Laganà AS (2017) Psychology of infertility and assisted reproductive treatment: the Italian situation. J Psychosom Obstet Gynecol 38:1–3. doi:10.1080/0167482X.2016.1244184

    Article  Google Scholar 

  30. Vitale SG, Petrosino B, La Rosa VL, Laganà AS (2016) Comment on “Differences in psychophysical well-being and signs of depression in couples undergoing their first consultation for assisted reproduction technology (ART): an Italian pilot study”. Eur J Obstet Gynecol Reprod Biol. doi:10.1016/j.ejogrb.2016.10.029

    PubMed  Google Scholar 

  31. Laganà AS, La Rosa VL, Rapisarda AM, Vitale SG (2017) Comment on: “Effect on sexual function of patients and patients’ spouses after midurethal sling procedure for stress urinary incontinence: a prospective single center study”. Low Urin Tract Symptoms 9:62. doi:10.1111/luts.12164

    Article  PubMed  Google Scholar 

  32. Vitale SG, Petrosino B, La Rosa VL et al (2016) A systematic review of the association between psychiatric disturbances and endometriosis. J Obstet Gynaecol Canada 38:1079–1080. doi:10.1016/j.jogc.2016.09.008

    Article  Google Scholar 

  33. Muscatello MR, Lorusso S, Bruno A et al (2016) Anger in women treated with assisted reproductive technology (ART): effects on mother and newborn. J Matern Fetal Neonatal Med 29:813–817. doi:10.3109/14767058.2015.1019459

    Article  PubMed  Google Scholar 

  34. Laganà AS, Condemi I, Retto G et al (2015) Analysis of psychopathological comorbidity behind the common symptoms and signs of endometriosis. Eur J Obstet Gynecol Reprod Biol 194:30–33. doi:10.1016/j.ejogrb.2015.08.015

    Article  PubMed  Google Scholar 

  35. Randall TC, Kurman RJ (1997) Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40. Obstet Gynecol 90:434–440

    Article  CAS  PubMed  Google Scholar 

  36. Koskas M, Azria E, Walker F et al (2012) Progestin treatment of atypical hyperplasia and well-differentiated adenocarcinoma of the endometrium to preserve fertility. Anticancer Res 32:1037–1043

    PubMed  Google Scholar 

  37. Rodolakis A, Biliatis I, Morice P et al (2015) European society of gynecological oncology task force for fertility preservation: clinical recommendations for fertility-sparing management in young endometrial cancer patients. Int J Gynecol Cancer 25:1258–1265. doi:10.1097/IGC.0000000000000493

    Article  PubMed  Google Scholar 

  38. Kaku T, Yoshikawa H, Tsuda H et al (2001) Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome. Cancer Lett 167:39–48

    Article  CAS  PubMed  Google Scholar 

  39. Falcone F, Laurelli G, Losito S et al (2017) Fertility preserving treatment with hysteroscopic resection followed by progestin therapy in young women with early endometrial cancer. J Gynecol Oncol 28:e2. doi:10.3802/jgo.2017.28.e2

    Article  PubMed  Google Scholar 

  40. Gallos ID, Yap J, Rajkhowa M, et al (2012) Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis. Am J Obstet Gynecol 207:266.e1–266.e12. doi:10.1016/j.ajog.2012.08.011

  41. Duska LR, Garrett A, Rueda BR et al (2001) Endometrial cancer in women 40 years old or younger. Gynecol Oncol 83:388–393. doi:10.1006/gyno.2001.6434

    Article  CAS  PubMed  Google Scholar 

  42. Leitao MM, Kehoe S, Barakat RR et al (2008) Accuracy of preoperative endometrial sampling diagnosis of FIGO grade 1 endometrial adenocarcinoma. Gynecol Oncol 111:244–248. doi:10.1016/j.ygyno.2008.07.033

    Article  PubMed  Google Scholar 

  43. Daniel AG, Peters WA (1988) Accuracy of office and operating room curettage in the grading of endometrial carcinoma. Obstet Gynecol 71:612–614

    CAS  PubMed  Google Scholar 

  44. Ushijima K, Yahata H, Yoshikawa H et al (2007) Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women. J Clin Oncol 25:2798–2803. doi:10.1200/JCO.2006.08.8344

    Article  CAS  PubMed  Google Scholar 

  45. Eltabbakh GH, Shamonki J, Mount SL (2005) Surgical stage, final grade, and survival of women with endometrial carcinoma whose preoperative endometrial biopsy shows well-differentiated tumors. Gynecol Oncol 99:309–312. doi:10.1016/j.ygyno.2005.06.010

    Article  PubMed  Google Scholar 

  46. Kinkel K, Kaji Y, Yu KK et al (1999) Radiologic staging in patients with endometrial cancer: a meta-analysis. Radiology 212:711–718. doi:10.1148/radiology.212.3.r99au29711

    Article  CAS  PubMed  Google Scholar 

  47. Dhar KK, NeedhiRajan T, Koslowski M, Woolas RP (2005) Is levonorgestrel intrauterine system effective for treatment of early endometrial cancer? Report of four cases and review of the literature. Gynecol Oncol 97:924–927. doi:10.1016/j.ygyno.2004.10.031

    Article  CAS  PubMed  Google Scholar 

  48. Wang Q, Guo Q, Gao S et al (2015) Fertility-conservation combined therapy with hysteroscopic resection and oral progesterone for local early stage endometrial carcinoma in young women. Int J Clin Exp Med 8:13804–13810

    PubMed  PubMed Central  Google Scholar 

  49. Vetvicka V, Laganà AS, Salmeri FM et al (2016) Regulation of apoptotic pathways during endometriosis: from the molecular basis to the future perspectives. Arch Gynecol Obstet 294:897–904. doi:10.1007/s00404-016-4195-6

    Article  CAS  PubMed  Google Scholar 

  50. Laganà AS, Salmeri FM, Triolo O et al (2016) Comments on “rhTNFR: Fc suppresses the development of endometriosis in a mouse model by downregulating cell proliferation and invasiveness”. Reprod Sci. doi:10.1177/1933719116653838

    PubMed  Google Scholar 

  51. Maniglio P, Ricciardi E, Laganà AS et al (2016) Epigenetic modifications of primordial reproductive tract: a common etiologic pathway for Mayer-Rokitansky-Kuster-Hauser Syndrome and endometriosis? Med Hypotheses 90:4–5. doi:10.1016/j.mehy.2016.02.015

    Article  CAS  PubMed  Google Scholar 

  52. Laganà AS, Triolo O, Salmeri FM et al (2016) Natural Killer T cell subsets in eutopic and ectopic endometrium: a fresh look to a busy corner. Arch Gynecol Obstet 293:941–949. doi:10.1007/s00404-015-4004-7

    Article  PubMed  Google Scholar 

  53. Sofo V, Götte M, Laganà AS et al (2015) Correlation between dioxin and endometriosis: an epigenetic route to unravel the pathogenesis of the disease. Arch Gynecol Obstet 292:973–986. doi:10.1007/s00404-015-3739-5

    Article  CAS  PubMed  Google Scholar 

  54. Salmeri FM, Laganà AS, Sofo V et al (2015) Behavior of tumor necrosis factor-α and tumor necrosis factor receptor 1/tumor necrosis factor receptor 2 system in mononuclear cells recovered from peritoneal fluid of women with endometriosis at different stages. Reprod Sci 22:165–172. doi:10.1177/1933719114536472

    Article  PubMed  PubMed Central  Google Scholar 

  55. Sturlese E, Salmeri FM, Retto G et al (2011) Dysregulation of the Fas/FasL system in mononuclear cells recovered from peritoneal fluid of women with endometriosis. J Reprod Immunol 92:74–81. doi:10.1016/j.jri.2011.08.005

    Article  CAS  PubMed  Google Scholar 

  56. Laganà AS, Giacobbe V, Triolo O et al (2016) Dienogest as preoperative treatment of submucous myomas for hysteroscopic surgery: a prospective, randomized study. Gynecol Endocrinol 32:408–411. doi:10.3109/09513590.2015.1128409

    Article  PubMed  Google Scholar 

  57. Laganà AS, Palmara V, Granese R et al (2014) Desogestrel versus danazol as preoperative treatment for hysteroscopic surgery: a prospective, randomized evaluation. Gynecol Endocrinol 30:794–797. doi:10.3109/09513590.2014.929658

    Article  PubMed  Google Scholar 

  58. Laganà AS, Vitale SG, Muscia V et al (2016) Endometrial preparation with Dienogest before hysteroscopic surgery: a systematic review. Arch Gynecol Obstet. doi:10.1007/s00404-016-4244-1

    Google Scholar 

  59. Gunderson CC, Fader AN, Carson KA, Bristow RE (2012) Oncologic and Reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 Adenocarcinoma: a systematic review. Gynecol Oncol 125:477–482. doi:10.1016/j.ygyno.2012.01.003

    Article  CAS  PubMed  Google Scholar 

  60. Montz FJ, Bristow RE, Bovicelli A et al (2002) Intrauterine progesterone treatment of early endometrial cancer. Am J Obstet Gynecol 186:651–657

    Article  CAS  PubMed  Google Scholar 

  61. Thigpen JT, Brady MF, Alvarez RD et al (1999) Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by the Gynecologic Oncology Group. J Clin Oncol 17:1736–1744. doi:10.1200/jco.1999.17.6.1736

    Article  CAS  PubMed  Google Scholar 

  62. Eftekhar Z, Izadi-Mood N, Yarandi F et al (2009) Efficacy of megestrol acetate (megace) in the treatment of patients with early endometrial adenocarcinoma: our experiences with 21 patients. Int J Gynecol Cancer 19:249–252. doi:10.1111/IGC.0b013e31819c5372

    Article  PubMed  Google Scholar 

  63. Kalogera E, Dowdy SC, Bakkum-Gamez JN (2014) Preserving fertility in young patients with endometrial cancer: current perspectives. Int J Womens Health 6:691–701. doi:10.2147/IJWH.S47232

    PubMed  PubMed Central  Google Scholar 

  64. Park JY, Kim DY, Kim JH et al (2013) Long-term oncologic outcomes after fertility-sparing management using oral progestin for young women with endometrial cancer (KGOG 2002). Eur J Cancer 49:868–874. doi:10.1016/j.ejca.2012.09.017

    Article  CAS  PubMed  Google Scholar 

  65. Park JY, Lee SH, Seong SJ et al (2013) Progestin re-treatment in patients with recurrent endometrial adenocarcinoma after successful fertility-sparing management using progestin. Gynecol Oncol 129:7–11. doi:10.1016/j.ygyno.2012.12.037

    Article  CAS  PubMed  Google Scholar 

  66. AlHilli MM, Mariani A, Bakkum-Gamez JN et al (2014) Risk-scoring models for individualized prediction of overall survival in low-grade and high-grade endometrial cancer. Gynecol Oncol 133:485–493. doi:10.1016/j.ygyno.2014.03.567

    Article  PubMed  PubMed Central  Google Scholar 

  67. De Angelis C, Carnevale A, Santoro G et al (2013) Hysteroscopic findings in women with menorrhagia. J Minim Invasive Gynecol 20:209–214. doi:10.1016/j.jmig.2012.10.009

    Article  PubMed  Google Scholar 

  68. Ianieri MM, Staniscia T, Pontrelli G et al (2016) A new hysteroscopic risk scoring system for diagnosing endometrial hyperplasia and adenocarcinoma. J Minim Invasive Gynecol 23:712–718. doi:10.1016/j.jmig.2016.02.017

    Article  PubMed  Google Scholar 

  69. Han AR, Kwon Y-S, Kim DY et al (2009) Pregnancy outcomes using assisted reproductive technology after fertility-preserving therapy in patients with endometrial adenocarcinoma or atypical complex hyperplasia. Int J Gynecol Cancer 19:147–151. doi:10.1111/IGC.0b013e31819960ba

    Article  PubMed  Google Scholar 

  70. Kim SM, Shin SJ, Bae JG et al (2016) Endometrial adenocarcinoma in a 13-year-old girl. Obstet Gynecol Sci 59:152–156. doi:10.5468/ogs.2016.59.2.152

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Unit of Gynecology and Obstetrics, Department of Human Pathology in Adulthood and Childhood “G. Barresi”, University of Messina, Via C. Valeria 1, 98125, Messina, Italy

    Salvatore Giovanni Vitale & Antonio Simone Laganà

  2. Department of Maternal and Child Health, Gavardo Hospital, Brescia, Italy

    Diego Rossetti

  3. Department of General Surgery and Medical Surgical Specialties, University of Catania, Catania, Italy

    Alessandro Tropea & Antonio Biondi

Authors
  1. Salvatore Giovanni Vitale
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Diego Rossetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alessandro Tropea
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Antonio Biondi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Antonio Simone Laganà
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Antonio Simone Laganà.

Ethics declarations

Funding

The work was not supported by any Grant/fund.

Conflict of interest

The authors have no proprietary, financial, professional or other personal interest of any nature in any product, service or company. The authors alone are responsible for the content and writing of the paper.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

For this type of study formal consent is not required.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vitale, S.G., Rossetti, D., Tropea, A. et al. Fertility sparing surgery for stage IA type I and G2 endometrial cancer in reproductive-aged patients: evidence-based approach and future perspectives. Updates Surg 69, 29–34 (2017). https://doi.org/10.1007/s13304-017-0419-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13304-017-0419-y

Keywords

Search

Navigation